These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 33815686)

  • 1. Neuropilins: C-end rule peptides and their association with nociception and COVID-19.
    Jobe A; Vijayan R
    Comput Struct Biotechnol J; 2021; 19():1889-1895. PubMed ID: 33815686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Broad and Differential Animal Angiotensin-Converting Enzyme 2 Receptor Usage by SARS-CoV-2.
    Zhao X; Chen D; Szabla R; Zheng M; Li G; Du P; Zheng S; Li X; Song C; Li R; Guo JT; Junop M; Zeng H; Lin H
    J Virol; 2020 Aug; 94(18):. PubMed ID: 32661139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of peptide binding to the SARS-CoV-2 host factor neuropilin.
    Jobe A; Vijayan R
    Heliyon; 2021 Oct; 7(10):e08251. PubMed ID: 34722943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A widespread viral entry mechanism: The C-end Rule motif-neuropilin receptor interaction.
    Balistreri G; Yamauchi Y; Teesalu T
    Proc Natl Acad Sci U S A; 2021 Nov; 118(49):. PubMed ID: 34772761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of SARS-CoV-2 viral entry upon blocking N- and O-glycan elaboration.
    Yang Q; Hughes TA; Kelkar A; Yu X; Cheng K; Park S; Huang WC; Lovell JF; Neelamegham S
    Elife; 2020 Oct; 9():. PubMed ID: 33103998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel Compounds Targeting Neuropilin Receptor 1 with Potential To Interfere with SARS-CoV-2 Virus Entry.
    Perez-Miller S; Patek M; Moutal A; Duran P; Cabel CR; Thorne CA; Campos SK; Khanna R
    ACS Chem Neurosci; 2021 Apr; 12(8):1299-1312. PubMed ID: 33787218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In silico identification and validation of inhibitors of the interaction between neuropilin receptor 1 and SARS-CoV-2 Spike protein.
    Perez-Miller S; Patek M; Moutal A; Cabel CR; Thorne CA; Campos SK; Khanna R
    bioRxiv; 2020 Sep; ():. PubMed ID: 32995772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of angiotensin-converting enzyme 2 and proteases in COVID-19 patients: A potential role of cellular FURIN in the pathogenesis of SARS-CoV-2.
    Drak Alsibai K
    Med Hypotheses; 2020 Oct; 143():109893. PubMed ID: 32512290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of potential SARS-CoV-2 entry inhibitors by targeting the interface region between the spike RBD and human ACE2.
    Gurung AB; Ali MA; Lee J; Farah MA; Al-Anazi KM
    J Infect Public Health; 2021 Feb; 14(2):227-237. PubMed ID: 33493919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coevolution, Dynamics and Allostery Conspire in Shaping Cooperative Binding and Signal Transmission of the SARS-CoV-2 Spike Protein with Human Angiotensin-Converting Enzyme 2.
    Verkhivker G
    Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33158276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Neuropilin-1 (NRP-1) in SARS-CoV-2 Infection: Review.
    Gudowska-Sawczuk M; Mroczko B
    J Clin Med; 2021 Jun; 10(13):. PubMed ID: 34202613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel Small-Molecule Inhibitors of the SARS-CoV-2 Spike Protein Binding to Neuropilin 1.
    Kolarič A; Jukič M; Bren U
    Pharmaceuticals (Basel); 2022 Jan; 15(2):. PubMed ID: 35215277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In silico investigation of critical binding pattern in SARS-CoV-2 spike protein with angiotensin-converting enzyme 2.
    Jafary F; Jafari S; Ganjalikhany MR
    Sci Rep; 2021 Mar; 11(1):6927. PubMed ID: 33767306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2 Spike protein co-opts VEGF-A/Neuropilin-1 receptor signaling to induce analgesia.
    Moutal A; Martin LF; Boinon L; Gomez K; Ran D; Zhou Y; Stratton HJ; Cai S; Luo S; Gonzalez KB; Perez-Miller S; Patwardhan A; Ibrahim MM; Khanna R
    bioRxiv; 2020 Sep; ():. PubMed ID: 32869019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can SARS-CoV-2 Virus Use Multiple Receptors to Enter Host Cells?
    Gadanec LK; McSweeney KR; Qaradakhi T; Ali B; Zulli A; Apostolopoulos V
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33498183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of SARS-CoV-2 Cell Entry Inhibitors by Drug Repurposing Using
    Choudhary S; Malik YS; Tomar S
    Front Immunol; 2020; 11():1664. PubMed ID: 32754161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2 pandemic and research gaps: Understanding SARS-CoV-2 interaction with the ACE2 receptor and implications for therapy.
    Datta PK; Liu F; Fischer T; Rappaport J; Qin X
    Theranostics; 2020; 10(16):7448-7464. PubMed ID: 32642005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 spike protein co-opts VEGF-A/neuropilin-1 receptor signaling to induce analgesia.
    Moutal A; Martin LF; Boinon L; Gomez K; Ran D; Zhou Y; Stratton HJ; Cai S; Luo S; Gonzalez KB; Perez-Miller S; Patwardhan A; Ibrahim MM; Khanna R
    Pain; 2021 Jan; 162(1):243-252. PubMed ID: 33009246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantum Dot-Conjugated SARS-CoV-2 Spike Pseudo-Virions Enable Tracking of Angiotensin Converting Enzyme 2 Binding and Endocytosis.
    Gorshkov K; Susumu K; Chen J; Xu M; Pradhan M; Zhu W; Hu X; Breger JC; Wolak M; Oh E
    ACS Nano; 2020 Sep; 14(9):12234-12247. PubMed ID: 32845122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scaffold morphing of arbidol (umifenovir) in search of multi-targeting therapy halting the interaction of SARS-CoV-2 with ACE2 and other proteases involved in COVID-19.
    Choudhary S; Silakari O
    Virus Res; 2020 Nov; 289():198146. PubMed ID: 32866534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.